Who Paid My Doc
Clifton Davis
Hospitalist Council Bluffs, IA Medical Doctor
NPI 1083077358 CMS profile 5690093
933 E Pierce St, Apt 601, Council Bluffs, IA 51503
General payments
$150
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Clifton Davis of Council Bluffs, IA is reported in the CMS Open Payments database as having received $150 across 8 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 49th percentile of Hospitalist profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $46 | 2 | |
| 2024 | General | $23 | 1 | |
| 2023 | General | $68 | 4 | |
| 2019 | General | $12 | 1 |
Beside peers
- Clifton Davis
- Hospitalist median
- Middle half of Hospitalist
- National median
In program year 2025, general payments to Clifton Davis were reported at $46. Among 6,882 Hospitalist profiles paid that year, the median was $86 and the middle half received between $30 and $191.
Show as a table
| Year | Clifton Davis | Hospitalist median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $12 | $96 | $28–$201 | $163 |
| 2020 | $0 | $48 | $19–$125 | $114 |
| 2021 | $0 | $70 | $23–$167 | $132 |
| 2022 | $0 | $85 | $27–$174 | $149 |
| 2023 | $68 | $89 | $30–$191 | $160 |
| 2024 | $23 | $95 | $29–$204 | $164 |
| 2025 | $46 | $86 | $30–$191 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 31 drugsPart D claims
1,057
Drug cost
$468,101
Branded share of claims
66%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ozempic Semaglutide | Brand | 91 | $108,990 | |
| Mounjaro Tirzepatide | Brand | 51 | $56,373 | |
| Jardiance Empagliflozin | Brand | 46 | $51,304 | |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | Brand | 17 | $35,281 | |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | Brand | 23 | $33,201 | |
| Tresiba Flextouch U-200 Insulin Degludec | Brand | 23 | $29,689 | |
| Tresiba Flextouch U-100 Insulin Degludec | Brand | 29 | $27,247 | |
| Trulicity Dulaglutide | Brand | 16 | $22,665 | |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | Brand | 28 | $15,512 | |
| Novolog Flexpen Insulin Aspart | Brand | 37 | $12,236 |
The 10 drugs with the highest cost, of 31 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 6,527 Part D prescribers listed as Endocrinology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 13 billing codesPaid by Medicare
$29,048
Medicare patients
216
Services billed
573
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 61% | |
| Arthritis | 46% | |
| Chronic kidney disease | 42% | |
| Depression | 35% | |
| Ischemic heart disease | 32% | |
| Heart failure | 24% | |
| Atrial fibrillation | 23% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
8 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Hospitalist in Iowa
Related records
Hospitalist in Iowa
Practitioners in the same specialty and state, ranked by reported value.
All Hospitalist
Everyone recorded under this specialty, nationwide.
Doctors in Iowa
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.